Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈÇÐȸ The 10th International Congress on Lipid & Atherosclerosis (ICoLA 2021) 1ÀÏÂ÷ : 2021-09-10±³À°ÀÏÀÚ : 2021-09-10
±³À°Àå¼Ò : ÄÜ·¡µåÈ£ÅÚ ¼¿ï(¿Â¶óÀÎ º´Çà)
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) The 10th International Congress on Lipid & Atherosclerosis (ICoLA 2021) 1ÀÏÂ÷ÁÖÃÖ±â°ü : Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈÇÐȸ
´ã´çÀÚ : ICoLA2021 »ç¹«±¹
¿¬¶ôó : 02-2135-3618
À̸ÞÀÏ :
secretariat@icola.org ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 700¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 27 ½Ã°£ 35ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í Àü¹®ÀÇ, ±³¼ö : 100,000¿ø / ÀüÀÓÀÇ, Àü°øÀÇ, ±ºÀÇ°ü, ¿¬±¸¿ø, Çлý µî : 4¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-10 Room 1 08:00~08:20 For today for tomorrow, cardiorenal benefit of dapagliflozin Jae Hyuk Lee(Myongji Hospital, Korea)
Åä·Ð 09-10 Room 1 08:20~08:30 Discussion ()
±³À°½Ã°£ 09-10 Room 2 08:00~08:20 Can my elderly AF patients benefit in anticoagulation? : broad data of Eliquis can tell Seung Yong Shin(Chung-Ang University, Korea)
Åä·Ð 09-10 Room 2 08:20~08:30 Discussion ()
±³À°½Ã°£ 09-10 Room 3 08:00~08:20 A novel strategy for the lipid management of recent ACS patients Jin Joo Park(Seoul National University, Korea)
±³À°½Ã°£ 09-10 Room 3 08:20~08:30 Discussion ()
±³À°½Ã°£ 09-10 Room 1+2+3 09:00~09:30 What's new in epidemiology of ASCVD & risk factors Raul Santos(University of Sao Paulo, Brazil)
ÈÞ½Ä 09-10 09:30~09:40 Break ()
±³À°½Ã°£ 09-10 Room 1 09:40~10:03 NAFLD, NASH & cardiovascular disease Masahiro Koseki(Osaka University, Japan)
±³À°½Ã°£ 09-10 Room 1 10:03~10:26 Leukocytes, inflammation, and atherosclerosis Marit Westerterp(University of Groningen, Netherlands)
±³À°½Ã°£ 09-10 Room 1 10:26~10:49 Heterogeneity of NAFLD the perspective of atherosclerosis Bo Kyung Koo(Seoul National University, Korea)
Åä·Ð 09-10 Room 1 10:49~11:15 Discussion ()
±³À°½Ã°£ 09-10 Room 2 09:40~10:03 Integration of new imaging or biomarkers to risk calculators Chang-Yeon Kim(Daegu Catholic University, Korea)
±³À°½Ã°£ 09-10 Room 2 10:03~10:26 Understanding cardiovascular risk: using risk scores and other risk-based testing in the contemporary era Ian Neeland(University Hospitals Cleveland Medical Center, USA)
±³À°½Ã°£ 09-10 Room 2 10:26~10:49 Risk model for CV risk assessment in Korean population Seung-Hwan Lee(The Catholic University of Korea, Korea)
Åä·Ð 09-10 Room 2 10:49~11:15 Discussion ()
±³À°½Ã°£ 09-10 Room 3 09:40~10:03 Mapping genetic associations to novel therapeutics for cardiometabolic disease Pradeep Natarajan(Harvard Medical School, USA)
±³À°½Ã°£ 09-10 Room 3 10:03~10:26 Clinical implication of recent epigenetic studies on CAD & dyslipidemia Sung Ho Park(UNIST, Korea)
±³À°½Ã°£ 09-10 Room 3 10:26~10:49 How can we derive biological relevance genetic studies on atherosclerosis? Mete Civelek(University of Virginia, USA)
Åä·Ð 09-10 Room 3 10:49~11:15 Discussion ()
±³À°½Ã°£ 09-10 Room 4 09:40~10:03 Myeloid cell heterogeneity in hyperlipidemic cardiovascular diseases Jae Hoon Choi(Hanyang University, Korea)
±³À°½Ã°£ 09-10 Room 4 10:03~10:26 Role of immune cells in the regression of atherosclerosis Edward A. Fisher(NYU Grossman School of Medicine, USA)
±³À°½Ã°£ 09-10 Room 4 10:26~10:49 Role of LYVE-1+ macrophage in arterial diseases Veronique Angeli(National University of Singapore, Singapore)
Åä·Ð 09-10 Room 4 10:49~11:15 Discussion ()
±³À°½Ã°£ 09-10 Room 5 09:40~10:03 Cellular plasticity in atherosclerosis Judith Sluimer(Maastricht University, Netherlands)
±³À°½Ã°£ 09-10 Room 5 10:03~10:26 New mechanism of vascular calcification Byeong Hwa Jeon(Chungnam National University, Korea)
±³À°½Ã°£ 09-10 Room 5 10:26~10:49 Phenotypic changes of VSMC in atherosclerosis Chang Seon Myung(Chungnam National University, Korea)
Åä·Ð 09-10 Room 5 10:49~11:15 Discussion ()
ÈÞ½Ä 09-10 11:15~11:25 Break ()
±âŸ 09-10 11:25~11:35 Opening Address ()
±³À°½Ã°£ 09-10 Room 1+2+3 11:35~12:05 Single cell RNA and antibody sequencing in women and men with cardiovascular disease Klaus Ley(La Jolla Institute for Immunology, USA)
±³À°½Ã°£ 09-10 Room 1 12:05~12:25 Insight for T2DM and/or metabolism syndrome with complication to manage dyslipidemia Seung-Hwan Lee(The Catholic University of Korea, Korea)
Åä·Ð 09-10 Room 1 12:25~12:35 Discussion ()
±³À°½Ã°£ 09-10 Room 2 12:05~12:25 Familial hypercholesterolemia: diagnosis and management Chan Joo Lee(Yonsei University, Korea)
Åä·Ð 09-10 Room 2 12:25~12:35 Discussion ()
±³À°½Ã°£ 09-10 Room 3 12:05~12:25 What are the optimal options of dyslipidemia management for your patients? based on treatment continuum Hyun Jae Kang(Seoul National University, Korea)
Åä·Ð 09-10 Room 3 12:25~12:35 Discussion ()
Åä·Ð 09-10 Room 4 12:25~12:35 Discussion ()
±³À°½Ã°£ 09-10 Room 4 12:05~12:25 Lipid management: to the perfection and state of art Hyo-In Choi(Sungkyunkwan University, Korea)
±³À°½Ã°£ 09-10 Room 1 13:05~13:12 Hippo/Mst1 is essential for adipogenic aging Je-Hyun Yoon(Medical University of South Carolina, USA)
±³À°½Ã°£ 09-10 Room 1 13:12~13:19 LncRNA H1 sponges miR223 to enhance proinflammatory changes of vascular smooth muscle cells Soo-jin Ann(Yonsei University, Korea)
±³À°½Ã°£ 09-10 Room 1 13:19~13:26 Development of hemodynamic biomarker for carotid atherosclerosis based on the results of in-vitro phantom study using 4D-flow MRI Don-Gwan An(Hanyang University, Korea)
±³À°½Ã°£ 09-10 Room 1 13:26~13:33 Effect of elevated uric acid by fructose overload on NASH and atherosclerosis Moe Fujii(Okayama University, Japan)
±³À°½Ã°£ 09-10 Room 1 13:33~13:40 Plasma oxidized LDL induces procoagulant profiles in subjects with borderline hypercholesterolemia by increasing lysophosphatidylcholine levels and Lp-PLA2 activity? Ximei Huang(Hannam University, Korea)
Åä·Ð 09-10 Room 1 13:40~14:05 Q&A ()
±³À°½Ã°£ 09-10 Room 3 13:05~13:12 Exploring the genetic associations between the use of statins and Alzheimer¡¯s disease Jibeom Lee(Gwangju Institue of Science and Technology, Korea)
±³À°½Ã°£ 09-10 Room 3 13:12~13:19 Triglyceride?glucose index is a useful marker for predicting atherosclerotic cardiovascular disease in young adults: a nationwide population-based cohort study Yun Kyung Cho(Hallym University, Korea)
±³À°½Ã°£ 09-10 Room 3 13:19~13:26 Combination of statin and ezetimibe versus statin monotherapy on cardiovascular disease and type 2 diabetes incidence among adults with impaired fasting glucose: a propensity-matched study You-Bin Lee(Sunkyunkwan University, Korea)
±³À°½Ã°£ 09-10 Room 3 13:26~13:33 Higher non-high-density lipoprotein cholesterol was higher associated with CVD comparing higher LDL-C in nine years follow up Sangmo Hong(Hanyang University, Korea)
±³À°½Ã°£ 09-10 Room 3 13:33~13:40 Zmpste24 deficiency accelerates atherosclerosis in vascular smooth muscle cells Soyoung Cho(Yonsei University, Korea)
Åä·Ð 09-10 Room 3 13:40~14:05 Q&A ()
±³À°½Ã°£ 09-10 Room 1+2+3 14:05~14:35 Optimal medical therapy to inhibit coronary plaque Ken-ichi Hirata(Kobe University, Japan)
ÈÞ½Ä 09-10 14:35~14:45 Break ()
±³À°½Ã°£ 09-10 Room 1 14:45~15:08 Is remnant lipoprotein atherogenic? Ki Hoon Han(University of Ulsan, Korea)
±³À°½Ã°£ 09-10 Room 1 15:08~15:31 New therapeutics based on TG metabolism Hye-Jin Yoo(Korea University, Korea)
±³À°½Ã°£ 09-10 Room 1 15:31~15:54 Update on ANGPTL3 inhibition trials Nathan Stitziel(University of Washington, USA)
Åä·Ð 09-10 Room 1 15:54~16:20 Discussion ()
±³À°½Ã°£ 09-10 Room 2 14:45~15:08 Latest target molecules in imaging early & late atherosclerosis Jin-Won Kim(Korea University, Korea)
±³À°½Ã°£ 09-10 Room 2 15:08~15:31 Molecular imaging in atherosclerosis Jung-joon Min(Chonnam National University, Korea)
±³À°½Ã°£ 09-10 Room 2 15:31~15:54 Update on invasive imaging of vulnerable plaque So-Yeon Choi(Ajou University, Korea)
Åä·Ð 09-10 Room 2 15:54~16:20 Discussion ()
±³À°½Ã°£ 09-10 Room 3 14:45~15:08 Endothelial cell epigenetic factors regulating atherosclerosis Hanjoong Jo(Emory University, USA)
±³À°½Ã°£ 09-10 Room 3 15:08~15:31 Update on endothelial cell as target of anti-atherosclerosis treatment Kyung-Sun Heo(Chungnam National University, Korea)
±³À°½Ã°£ 09-10 Room 3 15:31~15:54 ROS regulation in vascular cells Goo Taeg Oh(Ewha Womans University, Korea)
Åä·Ð 09-10 Room 3 15:54~16:20 Discussion ()
±³À°½Ã°£ 09-10 Room 4 14:45~15:03 Dietary cholesterol recommendation for cardiovascular risk Sung Nim Han(Seoul National University, Korea)
±³À°½Ã°£ 09-10 Room 4 15:03~15:21 Importance of dietary fatty acids in CV disease Gwang-woong Go(Hanyang University, Korea)
±³À°½Ã°£ 09-10 Room 4 15:21~15:39 Dietary fiber and dyslipidemia Ji Yeon Kim(Seoul National University of Science and Technology, Korea)
±³À°½Ã°£ 09-10 Room 4 15:39~15:57 Sodium dietary reference intakes based on CV disease Min-Jeong Shin(Korea University, Korea)
Åä·Ð 09-10 Room 4 15:57~16:20 Discussion ()
ÈÞ½Ä 09-10 16:20~16:30 Break ()
±³À°½Ã°£ 09-10 Room 1 16:30~16:53 What is trend & common points of latest lipid-lowering therapy guidelines? Jong-Young Lee(Sungkyunkwan University, Korea)
±³À°½Ã°£ 09-10 Room 1 16:53~17:16 Is current stratification of very-high risk appropriate? Sung Hee Choi(Seoul National University, Korea)
±³À°½Ã°£ 09-10 Room 1 17:16~17:39 Is current LDL-C target achievable? Hidenori Arai(National Center for Geriatrics and Gerontology, Japan)
Åä·Ð 09-10 Room 1 17:39~18:05 Discussion ()
±³À°½Ã°£ 09-10 Room 2 16:30~16:53 Optimal treatment & LDL-C target for intermediate/low risk population Samia Mora(Brigham and Women)
±³À°½Ã°£ 09-10 Room 2 16:53~17:16 Timing & candidate of combination treatment Sin-Gon Kim(Korea University, Korea)
±³À°½Ã°£ 09-10 Room 2 17:16~17:39 Is it worth to adjust lipid-lowering therapy by ethinicity & how? Mariko Harada-Shiba(National Cerebral and Cardiovascular Center Research Institute, Japan)
Åä·Ð 09-10 Room 2 17:39~18:05 Discussion ()
±³À°½Ã°£ 09-10 Room 3 16:30~16:53 Mechanism of vascular complications in obesity & metabolic syndrome Soo Lim(Seoul National University, Korea)
±³À°½Ã°£ 09-10 Room 3 16:53~17:16 Immunometabolic control in macrophages Ichiro Manabe(Chiba University, Japan)
±³À°½Ã°£ 09-10 Room 3 17:16~17:39 FABP as therapeutic target in ASCVD Masato Furuhashi (Sapporo University, Japan)
Åä·Ð 09-10 Room 3 17:39~18:05 Discussion ()
±³À°½Ã°£ 09-10 Room 4 16:30~16:53 New insights mouse models of diabetes-accelerated atherosclerosis Karin Bornfeldt(University of Washington, USA)
±³À°½Ã°£ 09-10 Room 4 16:53~17:16 Fatty liver disease and gut ecosystem: microbiome and metabolome Do Yup Lee(Seoul National University, Korea)
±³À°½Ã°£ 09-10 Room 4 17:16~17:39 Proteomic studies in atherosclerotic cardiovascular disease Kyung-Gon Kim(University of Ulsan, Korea)
Åä·Ð 09-10 Room 4 17:39~18:05 Discussion ()